Dr. Reddy's Laboratories Ltd. (RDY)
13.21
-0.02
(-0.15%)
USD |
NYSE |
Oct 23, 16:00
13.10
-0.11
(-0.83%)
After-Hours: 20:00
Dr. Reddy's Laboratories Market Cap : 11.00B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 11.00B |
| October 22, 2026 | 11.02B |
| October 21, 2026 | 10.99B |
| October 20, 2026 | 11.05B |
| October 19, 2026 | 10.90B |
| October 16, 2026 | 10.89B |
| October 15, 2026 | 10.75B |
| October 14, 2026 | 10.62B |
| October 13, 2026 | 10.64B |
| October 12, 2026 | 10.68B |
| October 09, 2026 | 10.40B |
| October 08, 2026 | 10.16B |
| October 07, 2026 | 10.22B |
| October 06, 2026 | 10.40B |
| October 05, 2026 | 10.26B |
| October 02, 2026 | 10.20B |
| October 01, 2026 | 10.20B |
| September 30, 2026 | 10.51B |
| September 29, 2026 | 10.70B |
| September 28, 2026 | 10.42B |
| September 25, 2026 | 10.20B |
| September 24, 2026 | 10.25B |
| September 23, 2026 | 10.32B |
| September 22, 2026 | 10.47B |
| September 21, 2026 | 10.33B |
| Date | Value |
|---|---|
| September 18, 2026 | 10.15B |
| September 17, 2026 | 10.15B |
| September 16, 2026 | 9.729B |
| September 15, 2026 | 9.621B |
| September 14, 2026 | 9.921B |
| September 11, 2026 | 9.913B |
| September 10, 2026 | 9.754B |
| September 09, 2026 | 9.896B |
| September 08, 2026 | 9.896B |
| September 04, 2026 | 9.971B |
| September 03, 2026 | 10.02B |
| September 02, 2026 | 10.14B |
| September 01, 2026 | 10.14B |
| August 31, 2026 | 10.10B |
| August 28, 2026 | 10.15B |
| August 27, 2026 | 10.13B |
| August 26, 2026 | 10.18B |
| August 25, 2026 | 10.28B |
| August 24, 2026 | 10.18B |
| August 21, 2026 | 10.15B |
| August 20, 2026 | 10.09B |
| August 19, 2026 | 10.09B |
| August 18, 2026 | 10.12B |
| August 17, 2026 | 10.09B |
| August 14, 2026 | 10.22B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 63.97B |
| Teva Pharmaceutical Industries Ltd. | 45.91B |
| AstraZeneca PLC | 531.90B |
| ANI Pharmaceuticals, Inc. | 1.668B |
| Corcept Therapeutics, Inc. | 9.266B |
Market Cap Related Metrics
| PE Ratio | 36.30 |
| PS Ratio | 3.092 |
| Price to Book Value | 2.731 |
| Price to Free Cash Flow | 357.00 |
| Price | 13.21 |
| Earnings Yield | 2.75% |
| Operating PE Ratio | 34.56 |
| Normalized PE Ratio | 35.64 |